language.en-US
  • EN
  • RU
Treatment of Hepatitis C and drug-resistant tuberculosis co-infection

3rd webinar of the Virtual Medical Consilium (VMC) on tuberculosis, held on December 4, 2020

Webinar agenda:

- Welcome and introduction. Dr. Askar Yedilbayev and Mr. Oleksandr Korotych, Department of Tuberculosis, Joint Program on Tuberculosis, HIV Infection and Viral Hepatitis, WHO Regional Office for Europe, Denmark, Dr. Elmira Gurbanova, VMC Coordinator.

- Current WHO recommendations for testing and treatment of Hepatitis C. Dr. Antons Mozalevskis, Division of HIV and Viral Hepatitis, Joint Program on Tuberculosis, HIV Infection and Viral Hepatitis, WHO Regional Office for Europe, Denmark.

- Treatment of co-infection Hepatitis C and DR-TB. Dr Askar Yedilbayev, Joint Program on Tuberculosis, HIV Infection and Viral Hepatitis, WHO Regional Office for Europe, Denmark.

- Treatment of Hepatitis C with direct-acting antivirals in MDR-TB patients in Armenia. Experience of the National TB Program and MSF. Dr. Naira Khachatryan, VMC expert.

- Questions and answers.

 

Video record of this webinar is available on Russian only

1. WHO HCV Recommendations_ENG.pdf 1. WHO HCV Recommendations_RUS.pdf 2. HCV_TB_treatment_ENG.pdf 2. HCV_TB_treatment_RUS.pdf 3. HCV_TB treatment_ Armenia_ENG.pdf 3. HCV_TB treatment_Armenia_RUS.pptx